Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without bevacizumab in advanced urothelial carcinoma/metastatic urothelial carcinoma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma
• Bladder Urothelial Carcinoma Ajcc V7
• Unresectable Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine HCl and Cisplatin

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2020-02-17